Novo Nordisk's Weight Loss Drug Wegovy In Short Supply, Yet Goes Ahead With UK Launch - Novo Nordisk (NYS

Logo BenzingaBenzinga
2023-09-05 12:36:18  • 3 mins

On Monday,Novo Nordisk A/SNVOintroducedits popular weight loss drug Wegovy (semaglutide injection) in the U.K., making it accessible through the National Health Service (NHS) weight management scheme for free prescriptions and in the private market.

However, the company has acknowledged that supply constraints will persistin the foreseeable future.

Some doctors express discomfort about Wegovy's private availability when substantial demand exists within the NHS.

Obesity rates in the U.K. are among the highest in Europe, with significant disparities between more affluent and less affluent areas.

Access to specialist weight management services within the NHS is limited, and individuals facing socioeconomic or language barriers may find itchallenging to access these services.

The implications of Wegovy being available privately, alongside its availability through the NHS, remain unclear.

Novo Nordisk is actively working to persuade European governments and insurers to reimburse Wegovy, positioning it as more than just a lifestyle drug.

Continue read on

Weight-loss jabs like Wegovy can significantly improve blood sugar control for diabetics, a study has found. Semaglutide, sold under the brand names Wegovy,...
Logo The IndependentThe Independent
2023-10-03 03:41:04  • 1 min
Weight-loss jabs can help people with type 2 diabetes control their blood sugar in the long-term, a study has found. Semaglutide, sold under the brand names...
Logo The IndependentThe Independent
2023-10-02 22:01:00  • 1 min
Danish pharma giant Novo Nordisk A/s NVO has set its sights on India for the introduction of its breakthrough weight-loss drug Wegovy. The company aims for a...
Logo BenzingaBenzinga
2023-09-29 12:31:44  • 1 min
An analytics firm Trilliant Health analysis revealed a significant surge in prescriptions for diabetes and obesity drugs like Ozempic and Wegovy during the...
Logo BenzingaBenzinga
2023-09-28 12:22:31  • 1 min
The study represents the first long-term, large-scale, real-world trial of the blockbuster drug, researchers said.
Logo FortuneFortune
2023-10-02 22:01:00  • 1 min
(RTTNews) - Apellis Pharmaceuticals, Inc. (APLS) announced the FDA has approved the EMPAVELI Injector. It is a single-use, on-body device designed to enhance...
Logo NasdaqNasdaq
2023-10-02 11:27:06  • 1 min
The European Medicines Agency (EMA) is set to address concerns related to patients taking drugs such as Novo Nordisk A/S's NVO Wegovy, Ozempic, and their...
Logo BenzingaBenzinga
2023-09-27 12:49:43  • 1 min
In a significant development, the FDA has updated the labeling for Novo Nordisk A/S's NVO Ozempic, a diabetes drug known for its weight loss side effect, to...
Logo BenzingaBenzinga
2023-09-27 15:52:50  • 1 min
Key Points U.S. health care providers wrote more than nine million prescriptions for Ozempic, Wegovy and similar and obesity drugs during the last three...
2023-09-27 14:28:30  • 1 min
Key Points Food companies are making big bets on snacking, but the rise of Wegovy, Ozempic and similar drugs could pose a threat to future sales growth....
2023-10-01 12:00:01  • 1 min
The number of people plagued by thoughts of suicide or self-harm while taking a popular weight-loss jab has quadrupled in the past two months, The Mail on...
Logo Daily MailDaily Mail
2023-09-30 21:01:14  • 1 min
(RTTNews) - Hoth Therapeutics, Inc. (HOTH) announced the Pre-IND meeting previously requested for HT-KIT with the FDA has been granted to receive written...
Logo NasdaqNasdaq
2023-10-02 12:51:04  • 1 min
(RTTNews) - Takeda (TAK) said that, following discussions with the U.S. Food and Drug Administration, it will voluntarily withdraw its lung cancer drug...
Logo NasdaqNasdaq
2023-10-03 02:57:32  • 1 min
Key Points Drugmakers spent nearly $500 million on advertisements for obesity and diabetes treatments in the U.S. during the first seven months of this year,...
2023-09-29 13:00:12  • 1 min
NEW YORK (AP) U.S. health officials plan to endorse a common antibiotic as a morning-after pill that gay and bisexual men can use to try to avoid some...
Logo U.S. News & World ReportU.S. News & World Report
2023-10-02 13:13:32  • 1 min
(RTTNews) - Basilea Pharmaceutica Ltd announced the FDA has accepted for filing the New Drug Application for the antibiotic ceftobiprole. The FDA has set...
Logo NasdaqNasdaq
2023-10-02 05:47:45  • 1 min
Swiss medical technology company Ypsomed YPHDF announced a long-term supply deal with Novo Nordisk A/S NVO for autoinjectors. Novo has been unable to keep...
Logo BenzingaBenzinga
2023-09-20 14:32:10  • 1 min
(RTTNews) - Cabaletta Bio, Inc. (CABA), a clinical-stage biotechnology company focused on targeted cell therapies for patients with autoimmune diseases,...
Logo NasdaqNasdaq
2023-10-02 12:15:06  • 1 min
The World Health Organization authorized a second malaria vaccine on Monday, a decision that could offer countries a cheaper and a more readily available...
Logo Global NewsGlobal News
2023-10-02 15:19:45  • 1 min
Key Points Shares of Structure Therapeutics surged after the biotech company's experimental obesity pill succeeded in a small early-stage trial. The...
2023-09-29 16:02:36  • 1 min